- Home
- ABEV vs RGC Comparison
ABEV vs RGC Comparison
Compare ABEV & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEV
- RGC
- Stock Information
- Founded
- ABEV 1885
- RGC 2014
- Country
- ABEV Brazil
- RGC Hong Kong
- Employees
- ABEV N/A
- RGC N/A
- Industry
- ABEV Beverages (Production/Distribution)
- RGC Medicinal Chemicals and Botanical Products
- Sector
- ABEV Consumer Staples
- RGC Health Care
- Exchange
- ABEV Nasdaq
- RGC Nasdaq
- Market Cap
- ABEV 37.1B
- RGC 38.6B
- IPO Year
- ABEV N/A
- RGC 2021
- Fundamental
- Price
- ABEV $2.26
- RGC $13.97
- Analyst Decision
- ABEV Hold
- RGC
- Analyst Count
- ABEV 4
- RGC 0
- Target Price
- ABEV $2.60
- RGC N/A
- AVG Volume (30 Days)
- ABEV 31.4M
- RGC 644.3K
- Earning Date
- ABEV 07-31-2025
- RGC 06-30-2025
- Dividend Yield
- ABEV 6.60%
- RGC N/A
- EPS Growth
- ABEV 2.96
- RGC N/A
- EPS
- ABEV 0.17
- RGC N/A
- Revenue
- ABEV $16,833,014,419.00
- RGC N/A
- Revenue This Year
- ABEV $9.06
- RGC N/A
- Revenue Next Year
- ABEV $5.19
- RGC N/A
- P/E Ratio
- ABEV $13.14
- RGC N/A
- Revenue Growth
- ABEV 13.76
- RGC N/A
- 52 Week Low
- ABEV $1.76
- RGC $0.09
- 52 Week High
- ABEV $2.64
- RGC $83.60
- Technical
- Relative Strength Index (RSI)
- ABEV 42.91
- RGC 46.62
- Support Level
- ABEV $2.19
- RGC $12.60
- Resistance Level
- ABEV $2.30
- RGC $14.26
- Average True Range (ATR)
- ABEV 0.05
- RGC 1.25
- MACD
- ABEV -0.00
- RGC 0.18
- Stochastic Oscillator
- ABEV 37.93
- RGC 23.60
About ABEV Ambev S.A.
Ambev is the largest brewer in Latin America and the Caribbean and is Anheuser-Busch InBev's subsidiary in the region. It produces, distributes, and sells beer and PepsiCo products in Brazil and other Latin American countries and owns Argentina's largest brewer, Quinsa. Ambev was formed in 1999 through the merger of Brazil's two largest beverage companies, Brahma and Antarctica. In 2004, Ambev combined with Canadian brewer Labatt, giving AB InBev a controlling interest of 62%.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.